A groundbreaking partnership between Bridge to Life Ltd, a leading company in organ preservation and machine perfusion technologies, and ULS Coimbra, one of Portugal’s largest hospitals, aims to enhance liver preservation techniques and improve the quality of life for transplant recipients. This collaboration coincides with the 32nd anniversary of ULS Coimbra’s liver transplant programme, marking a significant milestone in organ transplantation research. The collaboration seeks to leverage the strengths of both entities, highlighting the increasing importance of academic research and industry partnerships in the field of organ transplantation. By focusing on innovative preservation methods, the initiative aims to improve access…
Author: Zak Osei
Zak Osei
Zak Osei spent seven years in the entertainment industry before he started writing about it. He worked in production at an independent film company, moved to a talent agency handling TV and digital talent, and spent two years on the commercial side of a streaming platform before the round of redundancies that taught him not to confuse a subscription number with a business model. He writes about film, television, streaming, music, and the business of making things people watch. He is interested in what gets made and why, not what gets nominated and by whom. Zak lives in South East London. He watches more content than is medically advisable and considers it professional development.
Pure Perfection Skin Clinic Bags Third Major Award in 2024 Pure Perfection, a renowned skin clinic located in Rossett near Chester, has achieved a remarkable milestone by winning its third significant award of the year. The clinic, directed by esteemed professional Sara Cheeney, was recently honoured with the title of Provider of the Year – Wales at the prestigious Cutera Awards, which took place at Sopwell House Hotel in London. The awards were hosted by television presenter and journalist Anna Richardson. This accolade follows two earlier wins this year: the clinic was named Best Clinic Midlands and Wales at the…
Crohn’s & Colitis UK, the leading charity for Inflammatory Bowel Disease (IBD) in the UK, is calling on the Government to take urgent action to reduce waiting times for diagnosis and treatment for those living with Crohn’s Disease and Ulcerative Colitis. Today, the charity is delivering an open letter, signed by 35,000 people, to the Secretary of State for Health and Social Care, Wes Streeting, demanding change. The charity’s appeal coincides with the launch of a national consultation on the future of the NHS, which aims to address significant challenges within the health service, including long wait times. According to…
New data suggests that access to green spaces may not be the solution to mental health issues, with some of the most forested states in the US reporting higher-than-average mental illness rates. Findings from Eco Lodges Anywhere, based on government statistics, show that states such as Maine, where nearly 90% of the land is covered by forest, still report concerning levels of mental health challenges. According to the 2024 Mental Health in America report, compiled by Mental Health America, over 24% of Maine’s population experiences mental illness – well above the national average of 23.08%. This trend is mirrored in…
As the autumn season progresses, mental and emotional health has become a key concern for many, especially with students returning to school and professionals settling back into office life. Among young adults in particular, who are often experiencing newfound freedom and responsibility, mental health can be easily neglected. Jaya Jaya Myra, a bestselling author, TEDx speaker, and wellness expert, highlights the challenges young adults face as they transition into adulthood. With the pressures of university life or early career responsibilities, many young people struggle to manage their mental and emotional well-being. According to Myra, meditation and mindfulness can provide a…
Waters Corporation (NYSE: WAT) has announced the launch of a new set of tools designed to simplify and accelerate the analysis of large molecule RNA therapeutics using liquid chromatography-mass spectrometry (LC-MS) technology. The new offering includes sample preparation enzymes, reagents, and the waters_connect software, all aimed at enhancing sequence and modification confirmation of these complex molecules. These tools are expected to play a crucial role in the development of RNA-based pharmaceuticals, such as CRISPR single-guide RNA (sgRNA) and messenger RNA (mRNA) therapies. Large molecule RNA therapeutics have emerged as a significant advancement in modern pharmaceuticals, with the potential to address…
Research commissioned by Roche has revealed that half of respondents across 12 countries in Latin America and Europe have little or no awareness of the role human papillomavirus (HPV) plays in cervical cancer. The study, conducted by GWI, shows a significant knowledge gap, despite HPV being responsible for over 99% of cervical cancer cases globally. HPV is a common sexually transmitted virus and the leading cause of cervical cancer, which affects more than 600,000 women each year, resulting in over 340,000 deaths. Most of these cases occur in low-resource countries, where access to healthcare is limited. The World Health Organization…
Hansa Biopharma AB has announced promising results from a 12-month follow-up analysis of its investigational drug, HNSA-5487, as part of the NICE-01 trial. The drug is designed to cleave immunoglobulin G (IgG), a key antibody linked to several autoimmune diseases. In the trial, HNSA-5487 demonstrated rapid and robust reductions in IgG levels, lowering them by more than 95% just hours after treatment. Twelve months later, the follow-up analysis confirmed that IgG levels returned to normal six months post-dosing. These findings mirror the results seen with Hansa’s first-generation IgG-cleaving enzyme, imlifidase. No serious side effects were reported during the trial, with…
The International Iberian Nanotechnology Laboratory (INL) has announced a significant achievement: its Nanosafety Laboratory has received official recognition from the Portuguese Institute for Quality (IPQ) for meeting the rigorous compliance standards of the Organisation for Economic Co-operation and Development (OECD) Principles of Good Laboratory Practices (GLP). This certification reinforces INL’s commitment to advancing safe and reliable research in the field of nanotechnology. Following an extensive inspection in May 2024, the GLP certification validates that INL’s Nanosafety Laboratory adheres to the highest international standards in testing and assessing nanomaterials, particularly for industrial and agri-food applications. This achievement is a crucial aspect…
Ferring Pharmaceuticals has announced promising findings from the OPTIMISE study, which provides groundbreaking evidence for a treat-to-target (T2T) management strategy in patients with mild-to-moderate ulcerative colitis (M2M UC). The study highlights the effectiveness of using faecal calprotectin (FC) home monitoring in achieving significantly higher rates of endoscopic and clinical remission over a 12-month period compared to traditional symptom-based approaches. Ulcerative colitis is a chronic inflammatory bowel disease that can lead to recurring symptoms such as bloody diarrhoea, abdominal pain, and fatigue. Current treatment protocols typically begin with 5-aminosalicylic acid (5-ASA; mesalazine) as a first-line therapy, followed by a stepwise treatment…
